Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults...
17 insider purchases on record · latest filing 2024-03-08.
Insiders have also filed 429 sale transactions at IRWD.